Department of Palliative Care, Sakai Hospital, Kinki University Faculty of Medicine, Japan.
Jpn J Clin Oncol. 2013 Aug;43(8):788-94. doi: 10.1093/jjco/hyt074. Epub 2013 Jun 4.
Early palliative intervention in advanced cancer patients with metastatic non-small-cell-lung cancer has been shown to improve survival time. Possibly, palliative intervention at the time of outpatient care further improves patient survival time.
We performed a comparative study of late and early referrals of patients with advanced cancer to clarify the appropriate time for palliative intervention and the improvement in survival time.
Two hundred and one cancer patients, all since deceased, who were treated in our department over a period of 4 years were divided into two groups: patients who experienced outpatient services for <7 days (late referral group, 64 patients) and those who experienced outpatient services for ≥7 days (early referral group, 137 patients). Survival time, duration of chemotherapy and post-progression survival were retrospectively analyzed through examination of medical records.
Survival time of the early referral group was longer than that of the late referral group in all the cases (19.0 vs. 6.5 months, P < 0.001). Survival time in advanced non-small-cell lung cancer was 3.5 and 14.0 months (P = 0.010) and 16.5 and 20.9 months (P = 0.039) in advanced colorectal cancer, respectively. There was no significant difference in gastric cancer (P = 0.310). Post-progression survival in each group was 0.7 and 2.7 months (P = 0.018) in non-small-cell lung cancer.
The results of this study suggested that early outpatient referral and palliative intervention leads to improvement of the outcome in patients with advanced non-small-cell lung cancer and colorectal cancer. A prospective comparative study is warranted.
在转移性非小细胞肺癌的晚期癌症患者中进行早期姑息治疗已被证明可以延长生存时间。可能在门诊治疗时进行姑息治疗会进一步延长患者的生存时间。
我们进行了一项比较研究,比较晚期和早期将晚期癌症患者转介至姑息治疗,以明确姑息治疗的适当时间以及生存时间的改善。
将过去 4 年在我们科室接受治疗的 201 例癌症患者(均已死亡)分为两组:门诊服务时间<7 天的患者(晚期转介组,64 例)和门诊服务时间≥7 天的患者(早期转介组,137 例)。通过检查病历,回顾性分析生存时间、化疗持续时间和进展后生存时间。
早期转介组的所有患者的生存时间均长于晚期转介组(19.0 与 6.5 个月,P<0.001)。晚期非小细胞肺癌的生存时间分别为 3.5 和 14.0 个月(P=0.010)和 16.5 和 20.9 个月(P=0.039),晚期结直肠癌的生存时间分别为 6.2 和 15.1 个月(P=0.045)和 8.1 和 17.0 个月(P=0.029)。胃癌无显著差异(P=0.310)。各组进展后生存时间分别为非小细胞肺癌的 0.7 和 2.7 个月(P=0.018)。
本研究结果表明,早期门诊转介和姑息治疗可改善晚期非小细胞肺癌和结直肠癌患者的预后。需要进行前瞻性比较研究。